Patents by Inventor Robarts Research Institute

Robarts Research Institute has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS FOR REGULATION OF STEM CELLS
    Publication number: 20130209430
    Abstract: Methods are provided for increasing stem cells, hematopoietic progenitor/stem cells, mesenchymal progenitor/stem cells, mesodermal progenitor/stem cells, muscle progenitor/stem cells, or neural progenitor/stem cells in vivo in a mammalian subject. Methods are also provided for treating an immune related disease, a mesenchymal/mesoderm degenerative disease, or a neurodegenerative disease in a mammalian subject in need thereof.
    Type: Application
    Filed: January 8, 2013
    Publication date: August 15, 2013
    Applicants: ROBARTS RESEARCH INSTITUTE, UNIVERSITY OF WASHINGTON
    Inventors: UNIVERSITY OF WASHINGTON, ROBARTS RESEARCH INSTITUTE
  • USE OF A COMBINATION OF MYXOMA VIRUS AND RAPAMYCIN FOR THERAPEUTIC TREATMENT
    Publication number: 20130171106
    Abstract: The present invention relates to therapeutic use of a combination of Myxoma virus, including in combination with rapamycin. Treatment with rapamycin enhances the ability of Myxoma virus to selectively infect cells that have a deficient innate anti-viral response, including cells that are not responsive to interferon. The combination of rapamycin and Myxoma virus can be used to treat diseases characterized by the presence of such cells, including cancer. The invention also relates to therapeutic use of Myxoma virus that does not express functional M135R.
    Type: Application
    Filed: November 16, 2012
    Publication date: July 4, 2013
    Applicant: ROBARTS RESEARCH INSTITUTE
    Inventor: Robarts Research Institute